All terms in GO
| Label | Id | Description |
|---|---|---|
| vistamycin biosynthetic process | GO_1901152 | [The chemical reactions and pathways resulting in the formation of vistamycin.] |
| negative regulation of intermediate mesodermal cell fate determination | GO_0048396 | [Any process that stops, prevents, or reduces the frequency, rate or extent of intermediate mesoderm cell fate determination.] |
| paromomycin metabolic process | GO_1901153 | [The chemical reactions and pathways involving paromomycin.] |
| paromomycin catabolic process | GO_1901154 | [The chemical reactions and pathways resulting in the breakdown of paromomycin.] |
| aminoglycoside antibiotic catabolic process | GO_0030649 | [The chemical reactions and pathways resulting in the breakdown of an aminoglycoside antibiotic, any member of a group of broad spectrum antibiotics, of similar toxicity and pharmacology, that contain an aminodeoxysugar, an amino- or guanidino-substituted inositol ring, and one or more residues of other sugars. The group includes streptomycin, neomycin, framycetin, kanamycin, paromomycin, and gentamicin.] |
| paromomycin biosynthetic process | GO_1901155 | [The chemical reactions and pathways resulting in the formation of paromomycin.] |
| neomycin metabolic process | GO_1901156 | [The chemical reactions and pathways involving neomycin.] |
| neomycin catabolic process | GO_1901157 | [The chemical reactions and pathways resulting in the breakdown of neomycin.] |
| neomycin biosynthetic process | GO_1901158 | [The chemical reactions and pathways resulting in the formation of neomycin.] |
| intermediate mesoderm development | GO_0048389 | [The process whose specific outcome is the progression of the intermediate mesoderm over time, from its formation to the mature structure. The intermediate mesoderm is located between the lateral mesoderm and the paraxial mesoderm. It develops into the kidney and gonads.] |
| endosomal lumen acidification | GO_0048388 | [Any process that reduces the pH of the endosomal lumen, measured by the concentration of the hydrogen ion.] |
| intracellular pH reduction | GO_0051452 | [Any process that reduces the internal pH of a cell, measured by the concentration of the hydrogen ion.] |
| mesendoderm development | GO_0048382 | [The process whose specific outcome is the progression of the mesendoderm over time, from its formation to the mature structure. In animal embryos, mesendoderm development gives rise to both mesoderm and endoderm tissues.] |
| endoderm development | GO_0007492 | [The process whose specific outcome is the progression of the endoderm over time, from its formation to the mature structure. The endoderm is the innermost germ layer that develops into the gastrointestinal tract, the lungs and associated tissues.] |
| mesectoderm development | GO_0048383 | [The process whose specific outcome is the progression of the mesectoderm over time, from its formation to the mature structure. In animal embryos, mesectoderm development processes give rise to both mesoderm and ectoderm tissues.] |
| negative regulation of lateral mesodermal cell fate specification | GO_0048380 | [Any process that stops, prevents, or reduces the frequency, rate or extent of lateral mesoderm cell fate specification.] |
| lateral mesoderm structural organization | GO_0048381 | [The process that contributes to the act of creating the structural organization of the lateral mesoderm. This process pertains to the physical shaping of a rudimentary structure.] |
| positive regulation of retinoic acid receptor signaling pathway | GO_0048386 | [Any process that activates or increases the frequency, rate or extent of retinoic acid receptor signaling pathway activity.] |
| regulation of retinoic acid receptor signaling pathway | GO_0048385 | [Any process that modulates the frequency, rate or extent of retinoic acid receptor signaling pathway activity.] |
| negative regulation of retinoic acid receptor signaling pathway | GO_0048387 | [Any process that stops, prevents, or reduces the frequency, rate or extent of retinoic acid receptor signaling pathway activity.] |